Institut du Cancer de Montpellier (ICM)
Institut du Cancer de Montpellier (ICM)
Montpellier, France2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Not stated | 2026-07-28 | NCT06627595 | |
| First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer | Unresectable Locally Advanced Colorectal Cancer; Unresectable Metastatic Colorectal Cancer | Recruiting | Phase 1 / Phase 2 | 2025-12-22 | NCT06934538 |